U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186453186453Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsTerminatedNo Results AvailableBrain and Central Nervous System Tumors|Carcinoma of Unknown Primary|Leukemia|Lymphoma|Unspecified Childhood Solid Tumor, Protocol SpecificDrug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00112619
186454186454Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNo Results AvailableAccelerated Phase Chronic Myelogenous Leukemia|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid LeukemDrug: fludarabine phosphate|Radiation: total-body irradiation|Procedure: peripheral blood stem cell transplantation|Drug: cyclosporine|Drug: mycophenolate mofetil|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00112593
186455186455MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNo Results AvailablePancreatic CancerBiological: ipilimumabhttps://ClinicalTrials.gov/show/NCT00112580
186456186456Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesDrug: fludarabine phosphate|Drug: thiotepa|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00112567
186457186457Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaDrug: cytarabine|Drug: laromustine|Other: placebohttps://ClinicalTrials.gov/show/NCT00112554
186458186458Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerBiological: bevacizumab|Drug: gemcitabine hydrochloride|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00112528
186459186459Modafinil in Treating Fatigue in Patients With CancerActive, not recruitingNo Results AvailableCognitive/Functional Effects|Depression|Fatigue|Unspecified Adult Solid Tumor, Protocol SpecificDrug: modafinil|Procedure: cognitive assessment|Procedure: psychosocial assessment and care|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00112515
186460186460Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: Celecoxib|Drug: Isotretinoin|Drug: Temozolomide|Drug: Thalidomidehttps://ClinicalTrials.gov/show/NCT00112502
186461186461Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerCompletedHas ResultsSarcomaDrug: carboplatin|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00112489
186462186462Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNo Results AvailableRecurrent Melanoma|Recurrent Renal Cell Cancer|Stage IV Melanoma|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: bryostatin 1|Drug: temsirolimushttps://ClinicalTrials.gov/show/NCT00112476
186451186451Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNo Results AvailableNeuroblastoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol SpecificBiological: anti-thymocyte globulin|Drug: busulfan|Drug: cyclosporine|Drug: melphalan|Drug: methotrexate|Drug: methylprednisolone|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Procedure: umbilical cord blood transplantationhttps://ClinicalTrials.gov/show/NCT00112645
186463186463Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaActive, not recruitingNo Results AvailableAdult Alveolar Soft-part Sarcoma|Adult Angiosarcoma|Adult Epithelioid Sarcoma|Adult Extraskeletal Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Fibrous Histiocytoma|Adult MalignanDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00112463
186464186464A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)Active, not recruitingHas ResultsOsteoporosisDrug: MK0822|Drug: MK0822|Drug: MK0822|Drug: MK0822|Dietary Supplement: Vitamin D3|Dietary Supplement: Calcium Carbonate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00112437
186465186465Trial of Cardiac Magnetic Resonance Imaging (MRI) Versus Cardiac Catheterization Prior to Glenn OperationCompletedNo Results AvailableCongenital Heart DefectsProcedure: Diagnostic cardiac MRI|Procedure: Cardiac catheterizationhttps://ClinicalTrials.gov/show/NCT00112424
186466186466Comparison of Two Bronchodilator Inhalers in Pediatric AsthmaticsCompletedNo Results AvailableAsthmaDrug: Bronchodilatorhttps://ClinicalTrials.gov/show/NCT00112411
186467186467Head Injury Retrieval TrialTerminatedNo Results AvailableHead Injuries, ClosedProcedure: Extended interventions by advanced level prehospital providershttps://ClinicalTrials.gov/show/NCT00112398
186468186468A Pilot Study of Etanercept in DermatomyositisCompletedHas ResultsDermatomyositisDrug: Etanercept|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00112385
186469186469Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)CompletedNo Results AvailableCancerDrug: Ridaforolimushttps://ClinicalTrials.gov/show/NCT00112372
186470186470International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedHas ResultsCystic FibrosisDrug: AZLI 75 mg three times a day (TID)|Drug: Placebo three times a day (TID)https://ClinicalTrials.gov/show/NCT00112359
186471186471Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small-Cell Lung CarcinomaDrug: Cetuximab + platinum + gemcitabine|Drug: Platinum + Gemcitabinehttps://ClinicalTrials.gov/show/NCT00112346
186472186472Defining Central Circuits of PainCompletedNo Results AvailableDyspepsiaProcedure: fMRIhttps://ClinicalTrials.gov/show/NCT00112333
186473186473Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of FallotCompletedNo Results AvailableTetralogy of Fallot|Pulmonary Valve Insufficiency|Ventricular Dysfunction, RightProcedure: PVR plus RV remodeling|Procedure: Standard PVRhttps://ClinicalTrials.gov/show/NCT00112320
186474186474Magnetic Resonance Imaging Guided Gynecologic BrachytherapyCompletedNo Results AvailableCervix Neoplasms|Uterine Neoplasms|Vaginal Neoplasms|Vulvar NeoplasmsProcedure: Brachytherapyhttps://ClinicalTrials.gov/show/NCT00112307
186475186475Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedHas ResultsNon-Small-Cell Lung CarcinomaDrug: Paclitaxel (Taxane)|Drug: Docetaxel (Taxane)|Drug: Carboplatin|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00112294
186476186476A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart AttackTerminatedNo Results AvailableShock, CardiogenicDrug: Tilarginine Acetate Injection intravenous infusionhttps://ClinicalTrials.gov/show/NCT00112281
186477186477Quitlink : A Leveraging Solution to Tobacco CounselingCompletedNo Results AvailableSmokingBehavioral: QuitLink (office support system for quit line referral)https://ClinicalTrials.gov/show/NCT00112268
186478186478Partner Notification for Chlamydia in Primary CareCompletedNo Results AvailableChlamydia InfectionsBehavioral: Practice nurse-led partner notification|Behavioral: Referral to specialist genitourinary clinichttps://ClinicalTrials.gov/show/NCT00112255
186479186479Immunotherapy of Stage III/IV Melanoma PatientsCompletedNo Results AvailableMelanomaBiological: Montanide + Melan-A analogue peptide|Biological: Montanide + Melan-A analog peptide + NY-ESO-1 analog peptide + Mage10 peptide|Biological: Montanide + CpG-7909 / PF-3512676+Melan-A analog peptide + NY-ESO-1 analog peptide + Mage10 peptide|Biological: Montanide + CpG-7909/PF-3512676 + Melan-A native and analog peptides + NY-ESO-1 long peptide + Mage10 peptide|Biological: Montanide + CpG-7909/PF-3512676 + Melan-A native and analog peptides + NY-ESO-1 long peptide + Mage10 peptide + low dose IL-2https://ClinicalTrials.gov/show/NCT00112242
186480186480Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma PatientsCompletedNo Results AvailableMelanomaBiological: group 1|Biological: group 2|Biological: group 3|Biological: group 4https://ClinicalTrials.gov/show/NCT00112229
186452186452Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal TumorCompletedNo Results AvailableGastrointestinal Stromal TumorDrug: imatinib mesylate|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00112632

* Görseller ve İçerik tekif hakkına sahip olabilir